Literature DB >> 33657641

Mortality and clinical response of patients with bullous pemphigoid treated with rituximab.

D S Yoo1, J H Lee1, S-C Kim2, J H Kim1.   

Abstract

Entities:  

Year:  2021        PMID： 33657641     DOI： 10.1111/bjd.19890

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

1.  Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study.

Authors:  Yun-Ju Tsai; Yung-Tsu Cho; Chia-Yu Chu
Journal:  Am J Clin Dermatol       Date:  2022-05-17       Impact factor: 6.233

Review 2.  Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.

Authors:  Hideyuki Ujiie; David Rosmarin; Michael P Schön; Sonja Ständer; Katharina Boch; Martin Metz; Marcus Maurer; Diamant Thaci; Enno Schmidt; Connor Cole; Kyle T Amber; Dario Didona; Michael Hertl; Andreas Recke; Hanna Graßhoff; Alexander Hackel; Anja Schumann; Gabriela Riemekasten; Katja Bieber; Gant Sprow; Joshua Dan; Detlef Zillikens; Tanya Sezin; Angela M Christiano; Kerstin Wolk; Robert Sabat; Khalaf Kridin; Victoria P Werth; Ralf J Ludwig
Journal:  Front Med (Lausanne)       Date:  2022-06-09

3.  Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.

Authors:  Gérôme Bohelay; Marina Alexandre; Christelle Le Roux-Villet; Ishaï Sitbon; Serge Doan; Isaac Soued; Jason Shourick; Laurie Rousset; Benoît Mellottee; Michel Heller; Nicole Lièvre; Coralie Zumelzu; Florence Morin; Sabine Grootenboer-Mignot; Eric Gabison; Frédéric Caux; Catherine Prost-Squarcioni; Philippe Musette
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 4.  Immunopathology and Immunotherapy of Inflammatory Skin Diseases.

Authors:  Ahreum Song; Sang Eun Lee; Jong Hoon Kim
Journal:  Immune Netw       Date:  2022-02-14       Impact factor: 5.851

5.  Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities.

Authors:  Jue Liu; Tingkai Xiang; Wei Wang; Zhangyu Bu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-21

6.  Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid.

Authors:  H Rashid; J M Meijer; M C Bolling; B Horváth
Journal:  Br J Dermatol       Date:  2021-12-27       Impact factor: 11.113

Review 7.  Risk Factors for Mucosal Involvement in Bullous Pemphigoid and the Possible Mechanism: A Review.

Authors:  Xinyi Chen; Wenlin Zhao; Hongzhong Jin; Li Li
Journal:  Front Med (Lausanne)       Date:  2021-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.